FindTrial
Sign In

Effect and safety of tailored antiplatelet therapy based on platelet function testing in coil embolization for unruptured aneurysm

Effect and safety of tailored antiplatelet therapy based on platelet function testing in coil embolization for unruptured aneurysm

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005550
Enrollment
1780
Registered
2020-10-29
Start date
2019-05-20
Completion date
Unknown
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Bundang Jesaeng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent stent-assisted coiling for unruptured aneurysm between January 1, 2018 and December 31, 2018.

Exclusion criteria

Exclusion criteria: - Patients who underwent trapping, simple stenting, or flow diversion - Patients with modified Rankin scale sore 3 or more - Patients with other intracranial conditions including tumor. moyamoya disease, or arteriovenous malformation

Design outcomes

Primary

MeasureTime frame
Thromboembolic events—

Secondary

MeasureTime frame
Bleeding events;Neurological status—

Countries

Korea, Republic of

Contacts

Public ContactGyojun Hwang

Bundang Jesaeng Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026